Clinical value of Ovarian-Adnexal Reporting and Data System combined with contrast-enhanced ultrasound to identify benign and malignant tumors of the ovaries
|更新时间:2025-12-15
|
Clinical value of Ovarian-Adnexal Reporting and Data System combined with contrast-enhanced ultrasound to identify benign and malignant tumors of the ovaries
Clinical value of Ovarian-Adnexal Reporting and Data System combined with contrast-enhanced ultrasound to identify benign and malignant tumors of the ovaries
<0.01)。O-RADS诊断卵巢恶性肿瘤的灵敏度、特异度分别为93.0%、70.5%,CEUS的灵敏度、特异度分别为85.9%、87.5%,O-RADS联合CEUS的灵敏度、特异度分别为87.3%、88.6%。O-RADS联合CEUS诊断卵巢恶性肿瘤的曲线下面积(area under curve,AUC)与单独使用O-RADS(
Z
=2.920,
P
=0.004)或CEUS(
Z
=3.265,
P
=0.001)相比,差异有统计学意义。
结论:
O-RADS联合CEUS较单独使用O-RADS或CEUS鉴别卵巢良恶性肿瘤的临床价值更高。
Abstract
Objective:
To explore the clinical value of the Ovarian-Adnexal Reporting and Data System (O-RADS) combined with contrast-enhanced ultrasound (CEUS) to identify benign and malig
nant tumors of the ovaries.
Methods:
Retrospective analysis of 159 cases of ovarian tumors using transvaginal (transabdominal) ultrasound and O-RADS risk stratification was conducted. At the same time
combined with the CEUS
the ultrasound and CEUS features of benign and malignant ovarian tumors were compared
and the diagnostic efficacies of O-RADS
CEUS
and their combination in ovarian tumors were observed.
Results:
Taking pathology as the gold standard
among the 159 ovarian tumors in this study
88 cases were benign tumors and 71 cases were malignant tumors. The mean age
maximum tumor diameter
carbohydrate antigen (CA) 125
and human epididymis protein 4 (HE4) of malignant tumor patients were higher than those of benign tumor patients (
P
<0.01). There were differences in ultrasound characteristics
color Doppler score
ascites
CEUS enhancement time
enhancement level and enhancement morphology between benign and malignant ovarian tumors (
P
<0.01). The sensitivity and specificity of O-RADS in the diagnosis of ovarian malignant tumors were 93.0% and 70.5% respectively
and CEUS were 85.9% and 87.5% respectively
and O-RADS combined with CEUS were 87.3% and 88.6%respectively. The area under curve (AUC) of O-RADS combined with CEUS was significantly different from O-RADS (
Z
=2.920
P
=0.004) or CEUS (
Z
=3.265
P
=0.001).
Conclusion:
The clinical value of O-RADS combined with CEUS for ovarian tumors is higher than O-RADS or CEUS.